Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03812393
Title Evaluating the Efficacy of Neratinib on Live Cell HER2 Signaling Transduction Analysis Positive Triple Negative Breast (FACT-2)
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors West Cancer Center
Indications

triple-receptor negative breast cancer

Therapies

Carboplatin + Neratinib + Paclitaxel

Neratinib

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
West Cancer Center Recruiting Germantown Tennessee 38139 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field